High efficiency, small volume nucleic acid synthesis

US10563240B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10563240-B2
Application numberUS-201414775648-A
CountryUS
Kind codeB2
Filing dateMar 14, 2014
Priority dateMar 14, 2013
Publication dateFeb 18, 2020
Grant dateFeb 18, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nucleic acid molecules such as genomes).

First claim

Opening claim text (preview).

What is claimed is: 1. A method for assembling nucleic acid molecules, the method comprising: (a) forming a reaction mixture by combining: (1) two or more insert nucleic acid molecules, an acceptor nucleic acid molecule, and a plurality of oligonucleotides, wherein the plurality of oligonucleotides comprises (i) two oligonucleotides that share sequence complementarity with one terminus of a first insert nucleic acid molecule and a first terminus of the insertion site of the acceptor nucleic acid molecule, (ii) two oligonucleotides that share sequence complementarity with one terminus of a second insert nucleic acid molecule and a second terminus of the insertion site of the acceptor nucleic acid molecule, and (iii) one or more set of two oligonucleotides that each share sequence complementarity with one terminus of two different insert nucleic acid molecules, and wherein the total number of oligonucleotides is represented by the formula O=2+2I, where O is the total number of oligonucleotides and I is the number of insert nucleic acid molecules and wherein I>1, (2) a cell extract, and (3) a cell free protein composition comprising an exonuclease and, optionally, a single-stranded binding protein, and (b) incubating the reaction mixture formed in (a) under conditions which allow for the introduction of the insert nucleic acid molecules into the acceptor nucleic acid molecule. 2. The method of claim 1 , wherein the cell extract is obtained from a single cellular organism selected from the group consisting of: (a) Escherichia coli ( E. coli ); (b) Bacillus subtilis; (c) Schizosaccharomyces pombe ; and (d) Saccharomyces cerevisiae. 3. The method of claim 2 , wherein the Escherichia coli cells do not express redET genes. 4. The method of claim 3 , wherein the Escherichia coli cells are strain DH10B. 5. The method of claim 2 , wherein the cell extract is prepared by collecting a supernatant generated by centrifugation of a lysate of E. coli DH10B. 6. The method of claim 1 , wherein the exonuclease activity is provided by a DNA polymerase. 7. The method of claim 1 , wherein the single-stranded binding protein is encoded by T4 gene 32. 8. The method of claim 1 , wherein the number of insert nucleic acid molecules is two and the total number of oligonucleotides is six. 9. The method of claim 1 , wherein the exonuclease is T7 exonuclease. 10. The method of claim 9 , wherein the T7 exonuclease is present in a solution containing a buffer. 11. The method of claim 10 , wherein the buffer is Tris. 12. The method of claim 10 , wherein the solution containing the buffer also contains bovine serum albumin.

Assignees

Inventors

Classifications

  • General methods of preparing gene libraries, not provided for in other subgroups · CPC title

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10563240B2 cover?
The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nuclei…
Who is the assignee on this patent?
Life Technologies Corp, Thermo Fisher Scient Geneart Gmbh
What technology area does this patent fall under?
Primary CPC classification C12P19/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).